Dr. Vivek Kumar Pandey (Ph.D.)
Dr. Vivek Kumar Pandey (Ph.D.)
Research Scientist at Accutest Biologics Pvt Ltd., India
Verified email at iitr.res.in
Title
Cited by
Cited by
Year
Concurrent acetylation of FoxO1/3a and p53 due to sirtuins inhibition elicit Bim/PUMA mediated mitochondrial dysfunction and apoptosis in berberine-treated HepG2 cells
S Shukla, A Sharma, VK Pandey, S Raisuddin, P Kakkar
Toxicology and applied pharmacology 291, 70-83, 2016
282016
Activation of GSK3β/β-TrCP axis via PHLPP1 exacerbates Nrf2 degradation leading to impairment in cell survival pathway during diabetic nephropathy
A Mathur, VK Pandey, P Kakkar
Free Radical Biology and Medicine 120, 414-424, 2018
152018
PHLPP: a putative cellular target during insulin resistance and type 2 diabetes
A Mathur, VK Pandey, P Kakkar
Journal of Endocrinology 233 (3), R185-R198, 2017
132017
Emerging role of Unfolded Protein Response (UPR) mediated proteotoxic apoptosis in diabetes
VK Pandey, A Mathur, P Kakkar
Life sciences. 216:246-258., 2019
122019
Activation of PERK-eIF2α-ATF4 pathway contributes to diabetic hepatotoxicity: Attenuation of ER stress by Morin
VK Pandey, A Mathur, MF Khan, P Kakkar
Cellular signalling. 59: 41-52, 2019
52019
Morin prevents ER stress mediated hepatotoxicity by modulating PERK-eIF2α-ATF4 Axis in diabetic male Wistar rats
VK Pandey, A Mathur, P Kakkar
Free Radical Biology and Medicine 112, 154-155, 2017
22017
Regulation of β-TrCP Mediated Nrf2 Degradation by GSK3β during Hyperglycemic Renal Toxicity
A Mathur, VK Pandey, P Kakkar
Free Radical Biology and Medicine 112, 153, 2017
2017
The system can't perform the operation now. Try again later.
Articles 1–7